New Epigenetic Markers for Prostate Cancer Discovered
Oct. 3, 2022 New epigenetic biomarkers to predict more aggressive forms of prostate cancer have been …
Researchers Identify Drug Resistance Factors for Advanced Prostate Cancer
Sep. 22, 2022 Researchers have identified critical genomic changes in response to abiraterone acetate/prednisone, a standard treatment option for men with progressive, incurable and castration-resistant prostate …
HSD3B1 Gene Research Shows Association Between Genotype and Endometrial Cancer
Sep. 12, 2022 The HSD3B1 gene could hold clues for predicting and treating endometrial cancer, according to a novel finding. Researchers found a certain HSD3B1 genotype was more common in women with type 2 …
Considering Genetic Risk in Prostate Cancer Referrals Could Lead to Earlier Diagnosis
Aug. 18, 2022 A large-scale study looked at the impact of incorporating genetic risk for cancer into the GP triage and referral processes in the UK. The research concluded that considering genetic risk could …
Prostate Cancer Cases Risk Being Detected Too Late Due to Misleading Focus on Urinary Problems
Aug. 3, 2022 Men with early, curable stages of prostate cancer are missing opportunities to have their cancer detected because national guidelines and media health campaigns focus on urinary symptoms despite a …
With Just a Tablespoon of Blood, Researchers Aim to Transform Cancer Treatment
July 20, 2022 Researchers have developed a new blood test that provides unprecedented insight into a patient’s cancer make-up, potentially allowing doctors to better select treatment options that will improve …
Prognosis of Prostate Cancer Patients Improved
July 18, 2022 Prostate cancer is a common form of cancer. Researchers have now discovered a faster and easier way to determine who has an aggressive form of cancer, and who has …
Mechanism Leading to Drug Resistance in Prostate Cancer
June 15, 2022 Researchers reveal a mechanism by which prostate cancer cells become resistant through molecular modification of the androgen receptor protein and identify a potential treatment approach that could …
High-Intensity Focused Ultrasound (HIFU) Can Control Prostate Cancer With Fewer Side Effects
June 15, 2022 High-intensity focused ultrasound (HIFU) can help some men with prostate cancer avoid surgery or …
Hormones Contribute to Sex Disparities in Bladder Cancer, Study Shows
June 9, 2022 Male sex hormones interfere with the body’s ability to fight bladder cancer, likely explaining why males experience higher cancer rates and more deadly disease, according to a new …
New Cancer Subtype May Illuminate Treatment Strategy
May 27, 2022 Researchers have identified a previously unrecognized form of hormone therapy-resistant prostate cancer, as well as a set of molecules that drive its growth. This discovery opens the door to the …
Common Prostate Cancer Medications May Be Less Safe Than Previously Thought
May 25, 2022 Men taking either of the two most common oral medications for advanced prostate cancer who had also undergone hormone therapy to treat their disease were at higher risk of serious metabolic or …
How Tumor Cells Use Mitochondria to Keep Growing
May 10, 2022 Investigators have discovered that tumor cells use mitochondria to control their growth and detect stress that can destroy a tumor cell if it is not …
Less Prostate Cancer Screening Reduces Overdiagnosis but May Miss Aggressive Cases
Apr. 22, 2022 Over the past 15 years, public health authorities have downgraded recommendations for the prostate-specific antigen (PSA) test as a screening tool to reduce the overdiagnosis and overtreatment of men …
Novel Therapeutic Agents May Reduce the Oncogenesis of Metastatic Prostate Cancer
Apr. 13, 2022 Researchers have found that treating prostate cancer cells with novel cyclin-dependent kinase 19 (CDK19) and homologous cyclin-dependent kinase 8 (CDK8) inhibitors reduces their potential to migrate …
Researchers Look to Licorice for Promising Cancer Treatments
Apr. 6, 2022 A research review into molecular insights of a licorice-derived substance called glycyrrhizin for preventing or treating cancer suggests further research could lead to specific agents for clinical …
Cause of Metastasis in Prostate Cancer Discovered
Apr. 4, 2022 Prostate cancers remain localized in the majority of cases, giving affected individuals a good chance of survival. However, about 20% of patients develop incurable metastatic prostate cancer, …
MRI Innovation Makes Cancerous Tissue Light Up and Easier to See
Mar. 21, 2022 A new form of magnetic resonance imaging (MRI) that makes cancerous tissue glow in medical images could help doctors more accurately detect and track the progression of cancer over …
Metastatic Prostate Cancer on the Rise Since Decrease in Cancer Screenings
Mar. 14, 2022 A new study finds that the incidence rate of metastatic prostate cancer has significantly increased for men 45 and older and coincides with recommendations against routine prostate cancer …
New Risk Algorithm Would Improve Screening for Prostate Cancer
Mar. 8, 2022 Researchers developed an algorithm estimating a person’s risk of developing prostate cancer based on age and the levels of two prostate cancer markers, PSA and hK2 (human kalliknein peptidase). …
Monday, October 3, 2022
Thursday, September 22, 2022
Monday, September 12, 2022
Thursday, August 18, 2022
Wednesday, August 3, 2022
Wednesday, July 20, 2022
Monday, July 18, 2022
Wednesday, June 15, 2022
Thursday, June 9, 2022
Friday, May 27, 2022
Wednesday, May 25, 2022
Tuesday, May 10, 2022
Friday, April 22, 2022
Wednesday, April 13, 2022
Wednesday, April 6, 2022
Monday, April 4, 2022
Monday, March 21, 2022
Monday, March 14, 2022
Tuesday, March 8, 2022
Monday, February 28, 2022
Friday, February 18, 2022
Tuesday, February 15, 2022
Monday, February 7, 2022
Friday, January 28, 2022
Thursday, January 27, 2022
Tuesday, January 25, 2022
Thursday, January 13, 2022
Wednesday, January 12, 2022
Wednesday, January 5, 2022
Monday, November 29, 2021
Tuesday, November 16, 2021
Friday, November 5, 2021
Tuesday, November 2, 2021
Thursday, October 28, 2021
Tuesday, October 19, 2021
Thursday, October 7, 2021
Tuesday, October 5, 2021
Thursday, September 23, 2021
Thursday, September 16, 2021
Monday, August 23, 2021
Friday, August 13, 2021
Monday, August 2, 2021
Wednesday, July 7, 2021
Wednesday, May 19, 2021
Thursday, May 6, 2021
Monday, March 8, 2021
Wednesday, February 17, 2021
Thursday, February 11, 2021
Friday, January 15, 2021
Monday, January 11, 2021
Thursday, January 7, 2021
Tuesday, January 5, 2021
Monday, January 4, 2021
Monday, December 21, 2020
Tuesday, November 10, 2020
Wednesday, October 7, 2020
Tuesday, September 29, 2020
Thursday, September 3, 2020
Thursday, July 9, 2020
Saturday, June 20, 2020
Thursday, May 28, 2020
Tuesday, April 28, 2020
Thursday, April 9, 2020
Tuesday, April 7, 2020
Monday, March 23, 2020
Saturday, March 21, 2020
Wednesday, March 4, 2020
Friday, February 28, 2020
Monday, February 17, 2020
Monday, January 27, 2020
Source link Recent news surrounding prostate cancer has yielded a range of innovative discoveries in treatment and prevention, thanks to research advances. Scientists have identified a new combination of drugs that can be used to treat prostate cancer cells, as well as a gene mutation that can make prostate cancer more aggressive. Additionally, a breakthrough in MRI technology has resulted in improved accuracy for diagnosing the disease.
A recent study published in the journal Oncogene identified two drugs that could be combined to reduce the growth of prostate cancer cells. This discovery was made by studying changes to proteins found in the cells of prostate tumors, which researchers were able to exploit in laboratory settings. This finding could potentially pave the way for new treatments for the disease.
Another area of recent research uncovered a mutation in the gene PTEN, which is responsible for regulating tumor growth. This mutation can make prostate cancer more aggressive and has been found in up to 30% of prostate cancer cases. Scientists are now attempting to develop treatments to target this gene, which could help to reduce the spread of prostate cancer.
Moreover, a study published by the British Journal of Urology International showed that a new MRI technique is significantly more accurate at detecting seven forms of prostate cancer than traditional imaging methods. The new technique capitalizes on deep learning, a form of artificial intelligence, which allows computers to more accurately identify small changes in the enlarged prostate, making diagnosis more accurate and reliable.
As researchers around the world make further strides in understanding and combatting prostate cancer, the prognosis looks increasingly positive. These discoveries demonstrate how researchers are continually pushing the boundaries of prostate cancer research and providing hope for effective treatments and cures for this disease.
